J
John T. Wei
Researcher at University of Michigan
Publications - 395
Citations - 32685
John T. Wei is an academic researcher from University of Michigan. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 82, co-authored 385 publications receiving 30140 citations. Previous affiliations of John T. Wei include Johns Hopkins University & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
Simpa S. Salami,Folke Schmidt,Bharathi Laxman,Meredith M. Regan,David S. Rickman,Douglas S. Scherr,Gerardina Bueti,Javed Siddiqui,Scott A. Tomlins,John T. Wei,Arul M. Chinnaiyan,Mark A. Rubin,Martin G. Sanda,Martin G. Sanda +13 more
TL;DR: A clinical algorithm specifying biopsy for all patients with PSA ≥ 10 ng/ml, while restricting biopsy among those with PSC <10 ng/ ml to only those with detectable PCA3 or TMPRSS2:ERG in post-DRE urine, performed better than the individual biomarkers alone in predicting prostate cancer.
Journal ArticleDOI
Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.
Michael A. Joseph,Siobán D. Harlow,John T. Wei,Aruna V. Sarma,Rodney L. Dunn,Jeremy M. G. Taylor,Sherman A. James,Kathleen A. Cooney,Kay M. Doerr,James E. Montie,David Schottenfeld +10 more
TL;DR: This was the first population-based study undertaken in African-American men to evaluate putative risk factors for moderate to severe LUTS, including subcategories of obstructive and irritative urinary symptoms, and associations with specific lifestyle and medical history risk factors were described.
Journal ArticleDOI
A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [−2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness
Lori J. Sokoll,Martin G. Sanda,Ziding Feng,Jacob Kagan,Isaac A. Mizrahi,Dennis L. Broyles,Alan W. Partin,Sudhir Srivastava,Ian M. Thompson,John T. Wei,Zhen Zhang,Daniel W. Chan +11 more
TL;DR: In this prospective study, serum [−2]proPSA showed potential clinical utility for improving prostate cancer detection and was related to the risk of aggressive disease.
Journal ArticleDOI
Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).
Scott M. Gilbert,David P. Wood,Rodney L. Dunn,Alon Z. Weizer,Cheryl T. Lee,James E. Montie,John T. Wei +6 more
TL;DR: A recently developed reliable and disease‐specific quality of life instrument was used to measure urinary, sexual, and bowel function and bother domains in patients with bladder cancer managed with several different interventions, including cystectomy and endoscopic‐based procedures.
Journal ArticleDOI
Androgen deprivation therapy for prostate cancer results in significant loss of bone density.
John T. Wei,John T. Wei,Milton D. Gross,Milton D. Gross,Craig A. Jaffe,Craig A. Jaffe,Katherine Gravlin,Marcia Lahaie,Gary J. Faerber,Gary J. Faerber,Kathleen A. Cooney,Kathleen A. Cooney +11 more
TL;DR: Pre-existing osteopenia and osteoporosis were common in men with prostate cancer before initiating ADT, and both ADT and the duration of ADT were significantly associated with the loss of BMD in men.